Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies.
Glez-Vaz J, Azpilikueta A, Olivera I, Cirella A, Teijeira A, Ochoa MC, Alvarez M, Eguren-Santamaria I, Luri-Rey C, Rodriguez-Ruiz ME, Nie X, Chen L, Guedan S, Sanamed MF, Perez Gracia JL, Melero I.
Glez-Vaz J, et al. Among authors: guedan s.
J Immunother Cancer. 2022 Mar;10(3):e003532. doi: 10.1136/jitc-2021-003532.
J Immunother Cancer. 2022.
PMID: 35236742
Free PMC article.